Consumer Defensive
Twinlab Consolidated Holdings, Inc.(TLCC)
Live Price
Offline$0.0004
+0.00% today
1Y Change
-20.00%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- โ
- Revenue Growth
- -20.9%
- EPS Growth
- -66.9%
- Dividend Yield
- 0.0%
Coverage: 251 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Twinlab Consolidated Holdings, Inc. (TLCC) is a Consumer Defensive stock with listed on OTC. The stock last traded around $0.00 and down 20.0% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of -20.9%, EPS growth of -66.9%, a dividend yield of 0.0%. What stands out right now is revenue -20.9%, EPS -66.9%, free cash flow +165.7% with operating margin -10.2% and ROIC 3.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TLCC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-20.9% vs +1.7% peer median
Operating Margin
Below sector median
-10.2% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Oct 16, 2025, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -20.9% and EPS is at -66.9%, with operating margin around -10.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Oct 16, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Jun 2, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 May 29, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TLCC
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TLCC Max Drawdown
-33.33%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TLCC and SPY.
Company Overview
Twinlab Consolidated Holdings, Inc.
Other OTC
Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, and sports nutrition products under the Twinlab brand; healthy aging and beauty products under the Reserveage Nutrition and ResVitale brands; diet and energy products under the Metabolife; and a line of herbal teas under the Alvita brand. It also acts as contract manufacturer for private label customers. The company sells its products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, stick packs, sprays, and powders primarily through health and natural food stores, supermarkets, mass market retailers, specialty stores retailers, online retailers, and websites. Twinlab Consolidated Holdings, Inc. was founded in 2013 and is based in Boca Raton, Florida.
- Leadership
- Anthony J. Zolezzi
- IPO Date
- May 7, 2015
- Employees
- 17
- Street Address
- 4800 T-Rex Avenue
- Mailing
- Boca Raton, FL, 33431
- Region
- Boca Raton, FL, US
- Reporting Currency
- USD
- Investor Line
- 561 443 4301
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.0
- Price/Book
- โ
Growth
- Revenue
- -20.9%
- EPS
- -66.9%
- Free Cash Flow
- +165.7%
Profitability
- Gross Margin
- 36.8%
- Operating Margin
- -10.2%
- Net Margin
- -100.7%
- ROE
- 10.4%
- ROIC
- 3.3%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.04
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.